---
title: "Long Grove Pharmaceuticals: Cyclophosphamide for Injection — FDA announcement Jul 24, 2026 | Is It on Recall"
description: "Presence of particulate matter identified as steel"
url: https://isitonrecall.com/recall/fdapress-c7d2516f1f4bd2c7-long-grove-pharmaceuticals-cyclophosphamide-for-injection/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Long Grove Pharmaceuticals: Cyclophosphamide for Injection — FDA announcement Jul 24, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jul 24, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Cyclophosphamide for Injection
- **Reason**: Presence of particulate matter identified as steel
- **Classification**: Not supplied
- **Recalling firm**: Sunny Pharmtech, Inc.
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: c7d2516f1f4bd2c7

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injection-usp-user-level-due)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Product Name / Strength \| Dosage Form / Package \| NDC \| Lot Number \| Expiration Date; Cyclophosphamide for Injection, USP \| 1 g/vial, 50mL vial \| 81298-8112-1 \| C23019V1 \| Oct-2026; Cyclophosphamide for Injection, USP \| 1 g/vial, 50mL vial \| 81298-8112-1 \| C24015V1 \| Apr-2027; Cyclophosphamide for Injection, USP \| 2 g/vial, 100 mL vial \| 81298-8114-1 \| V24010V1 \| Mar-2027; Online: \| Complete and submit the report at www.fda.gov/medwatch/report.htm; Regular Mail: \| Download the reporting form at www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a form; complete and return it to the address on the pre-addressed form.; Fax: \| Submit the completed form to 1-800-FDA-0178. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| Product Name / Strength | Dosage Form / Package | NDC | Lot Number | Expiration Date |
| --- | --- | --- | --- | --- |
| Cyclophosphamide for Injection, USP | 1 g/vial, 50mL vial | 81298-8112-1 | C23019V1 | Oct-2026 |
| Cyclophosphamide for Injection, USP | 1 g/vial, 50mL vial | 81298-8112-1 | C24015V1 | Apr-2027 |
| Cyclophosphamide for Injection, USP | 2 g/vial, 100 mL vial | 81298-8114-1 | V24010V1 | Mar-2027 |

**FDA company announcement, table 2**

| Field | Details |
| --- | --- |
| Online: | Complete and submit the report at www.fda.gov/medwatch/report.htm |
| Regular Mail: | Download the reporting form at www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a form; complete and return it to the address on the pre-addressed form. |
| Fax: | Submit the completed form to 1-800-FDA-0178. |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injection-usp-user-level-due).

## Distribution

The affected Product is packaged as 1 g/vial, one 50 mL single-dose vial in a carton (NDC 81298-8112-1) and as a 2 g/vial, one 100 mL single-dose vial in a carton (NDC 81298-8114-1). The affected product was distributed to wholesalers, distributors, hospitals and pharmacies from May 2024 to October 2024 and can be identified using the information below. The three recalled lots (C23019V1, C24015V1, V24010V1) will remain within expiry until October 2026, April 2027, and March 2027, respectively.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Jul 24, 2026
- **Company announcement date**: Jul 24, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall may contact Sunny Pharmtech, Inc. at 886-3-4809168, Ext. 7205 or ra@sunnypharmtech.com, Monday through Friday from 9AM to 5PM GMT+8. Consumers should contact their physician or healthcare provider if they have experienced any problem that may be related to taking or using this drug product and should not stop or change prescribed treatment without consulting a healthcare professional.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injection-usp-user-level-due)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Sunny Pharmtech Inc. records](https://isitonrecall.com/brand/sunny-pharmtech-inc/)